NewsBenzingaBarclays Maintains Equal-Weight on PulteGroup, Lowers Price Target to $109 Barclays Maintains Equal-Weight on PulteGroup, Lowers Price Target to $109 Benzinga 2026.10.23 13:39 (GMT+0) Open on Benzinga Other news Here's How Much $100 Invested In Royalty Pharma 10 Years Ago Would Be Worth Today CORRECTION: 3M Authorizes Additional $6B Stock Buyback, Bringing Total Share Repurchase Capacity To $7.5B 3M Reaches Broad Resolution Of AFFF Personal Injury Litigation; 3M Will Make A Pre-Tax $7.35B Nominal Commitment Over Nine Years, With A Present Value Of $5.8B UPDATE: Tarsus Pharmaceuticals Q3 Adj. EPS $(0.78) Beats $(2.73) Estimate, Sales $194.569M Beat $186.598M Estimate UPDATE: Precision BioSciences Q3 Adj. EPS $(0.74) Beats $(0.85) Estimate Hecla Mining Q3 EPS $0.22 Beats $0.16 Estimate, Sales $394.820M Beat $340.000M Estimate
CORRECTION: 3M Authorizes Additional $6B Stock Buyback, Bringing Total Share Repurchase Capacity To $7.5B
3M Reaches Broad Resolution Of AFFF Personal Injury Litigation; 3M Will Make A Pre-Tax $7.35B Nominal Commitment Over Nine Years, With A Present Value Of $5.8B
UPDATE: Tarsus Pharmaceuticals Q3 Adj. EPS $(0.78) Beats $(2.73) Estimate, Sales $194.569M Beat $186.598M Estimate
